- Home
- RNXT vs BGI Comparison
RNXT vs BGI Comparison
Compare RNXT & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNXT | BGI |
|---|---|---|
| Founded | 2012 | 1879 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 22.7M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RNXT | BGI |
|---|---|---|
| Price | $0.95 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 286.7K | 27.7K |
| Earning Date | 11-13-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $928,000.00 | ★ $136,846,182.00 |
| Revenue This Year | $2,795.35 | N/A |
| Revenue Next Year | $272.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $0.70 | $0.56 |
| 52 Week High | $1.69 | $2.03 |
Technical Indicators
Market Signals| Indicator | RNXT | BGI |
|---|---|---|
| Relative Strength Index (RSI) | 51.82 | 35.97 |
| Support Level | $0.92 | $1.00 |
| Resistance Level | $0.93 | $1.09 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 81.94 | 20.05 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.